Monitor for potential downward pressure on the stock ahead of next earnings or any lack of positive catalysts; consider this cluster as a negative signal from top executives who may have visibility into near-term challenges.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 3 $20.17entry
- T+1 · 9mo ago +2.48%α +1.72% · $20.67
- T+5 · 8mo ago −7.44%α −6.96% · $18.67
- T+20 · 8mo ago −5.40%α −1.00% · $19.08
- T+60 · 6mo ago +21.47%α +11.15% · $24.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple C-suite executives at BioLife Solutions sold shares in a coordinated cluster over the past week, with total open-market sales amounting to approximately $2.0 million. The majority of the activity was driven by Chief Quality and Operations Officer Karen Foster, who sold nearly $1.95 million worth of stock, representing the bulk of the insider activity.
Key Financial Metrics
Key Facts
- 7 open-market sales by C-suite executives over a 7-day period
- Total value of sales: ~$2.0 million
- Karen Foster (Chief Quality and Operations) sold 97,884 shares for ~$1.96 million
- All transactions were open-market sales (S code), not forced or tax-related disposals
- Sales represent ~0.21% of company's $959M market cap
Financial Impact
$2.0 million in insider sales over 7 days, representing 0.21% of market cap
Risk Factors
- Insider selling could signal lack of confidence in near-term prospects
- Potential for negative market perception leading to short-term price weakness
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-BLFS-1773094298667 |
Track record
15 reports on BLFS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 6, 202610d ago Institutional Cluster Bearish 4/10 No price data
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 No price data
- Oct 16, 20264w ago 15-12G Neutral 4/10 No price data
- Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
- Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
- Oct 6, 20265w ago 8-K Bullish 7/10 Entry $39.00 No price data
- Sep 30, 20266w ago 425 Neutral 4/10 Entry $38.85 No price data
- Sep 30, 20266w ago DEFA14A Neutral 4/10 Entry $38.85 No price data
- Sep 24, 20267w ago SC 13G Neutral 4/10 Entry $38.58 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers